VeroScience News
Most Popular VeroScience Story
Diabetes drug gets FDA nod, but who'll sell it?
These days, diabetes is where it's at. There's so much activity in the diabetes business, it's tough to keep track. Eli Lilly and Amylin-- have they submitted their app for once-weekly Byetta? What's... Read more...
Latest Headlines
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
